NASAL LACRIMAL STENT MARKET ANALYSIS
Nasal Lacrimal Stent Market- Drivers
The nasal lacrimal stent market size is expected to increase over the forecast period owing to ongoing research on products to treat Epiphora and Dacryocystorhinostomy disease conditions. For instance, October 2019, Alon Kahana from University of Michigan sponsored a study aimed to evaluate safety and efficacy of the slit stent ii lacrimal stent for treatment of nasolacrimal duct obstruction.
Furthermore, availability of advanced products is expected to drive growth of this market. The FCI Ophthalmics Company offers products such as Nunchaku and BIKA intubation system, a bicanalicular stent which is used to drain tears by capillary.
Nasal Lacrimal Stent Market- Restraints
Alternative treatment available for epiphora medical conditions is major restraining factor of nasal lacrimal stent market. Most pharmaceuticals companies are focused on developing promising drugs which are indicated for treatment of ophthalmic diseases.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 